17-45845306-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_175882.3(SPPL2C):c.400C>A(p.Leu134Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00103 in 1,614,060 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_175882.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPPL2C | NM_175882.3 | c.400C>A | p.Leu134Met | missense_variant | 1/1 | ENST00000329196.7 | NP_787078.2 | |
MAPT-AS1 | NR_024559.1 | n.35-1145G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPPL2C | ENST00000329196.7 | c.400C>A | p.Leu134Met | missense_variant | 1/1 | NM_175882.3 | ENSP00000332488 | P1 | ||
MAPT-AS1 | ENST00000634876.2 | n.183-1145G>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000841 AC: 128AN: 152226Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000646 AC: 162AN: 250880Hom.: 0 AF XY: 0.000604 AC XY: 82AN XY: 135666
GnomAD4 exome AF: 0.00105 AC: 1536AN: 1461716Hom.: 1 Cov.: 30 AF XY: 0.00101 AC XY: 738AN XY: 727162
GnomAD4 genome AF: 0.000840 AC: 128AN: 152344Hom.: 0 Cov.: 33 AF XY: 0.000698 AC XY: 52AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2021 | The c.400C>A (p.L134M) alteration is located in exon 1 (coding exon 1) of the SPPL2C gene. This alteration results from a C to A substitution at nucleotide position 400, causing the leucine (L) at amino acid position 134 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at